All News

Biosimilars in the pharmacy benefit are as effective as their reference drug, but it’s important for the pharmacist to clarify this to patients.

This finding underlines the need for methods that address multiple genomic alterations and targeted therapies effective in tumors driven by variations in suppressor genes or transcription factors.

The biosimilar landscape is growing, but the FDA should leverage analytical data to efficiently determine the quality of these products and propel them toward approval, according to a session at the Academy of Managed Care Pharmacy’s Nexus 2023 conference.

Understanding the recommended ages for vaccination is crucial to properly advise patients and parents who have questions

Approximately 96% physicians feel it is important to assess patients aged 60 years and older for cognitive impairment, but 48% of these patients have no had assessments from their physician.

The products include Indomethacin 50 mg suppositories, Fluocinolone Acetonide Oil 0.01%, GA Depot 40 mg, Saxagliptin Tablets, 2.5 mg and 5 mg

The FDA is the only authority that can designate a biosimilar as interchangeable with its reference product, which requires that the product has similar clinical results for the same indication.

A panel hosted by HOPA, ACCC, and AVAHO discusses strategies to ensure patient access to treatment.

Latinx teens suffering with mental health issues are at risk of developing cardiovascular conditions in their future.

Areas of focus for specialty medications include biosimilars, cancer treatments, and drugs across disease states such as inflammatory conditions, HIV, and multiple sclerosis.

Pilocarpine improves near visual acuity by pupil modulation, leading to an increased ability to focus on nearby objects.

This patient population has had low survival rates with available treatments.

Twice-daily tenapanor tablets are recommended for patients with chronic kidney disease who are on dialysis, unresponsive or intolerant of any dose of a phosphate binder therapy.

Jensen notes that although she expects there will be a lot of FDA approvals in 2023 and 2024, there likely will not be another biosimilar “boom” until 2025.

Following the results of a meta-analysis that reviewed biosimilar trial design and endpoints, investigators urge for greater biosimilar uptake initiatives.

The approval marks the first and only once-daily target therapy for generalized myasthenia gravis for self-administration in this patient population.

Jeff J, Mclntyre, MA, Vice President of Liver Health Programs, Global Liver Institute, discussed the clinical and economic burden of NASH

Medically integrated dispensing specialty pharmacies can connect patient medical and pharmacy records to improve medication adherence and help patients to safely stay on them for longer.

Grace Yun, PharmD, and pharmacy manager at St. Francis Hospital, discussed the value of the pharmacist and how she sees the future of pharmacy evolving.

A specialist in adult, child, and adolescent psychiatry discusses the challenges in ADHD treatment for both patients and providers, as well as insights from a recent survey of health care professionals.

In the clinical setting, psychedelic medicine has promise as a safe and efficacious treatment for PTSD, TBIs, and other mental health issues.

PLCOm2012 uses additional parameters to predict the risk of lung cancer and was found more effective when identifying both Indigenous and non-Indigenous individuals with lung cancer.

As pharmacists provide more health care services, opportunities arise for more sophisticated patient engagement and billing solutions that drive patient satisfaction and increased loyalty.

The products include Abacavir/Dolutegravir/Lamivudine, Lisaftoclax (APG-2575), Zuranolone (Zurzuvae), Ebola Zaire Vaccine.

The Act is part of a federal attempt to streamline the research process for medical marijuana and provide more attainable security requirements

Recent FDA findings highlight that a major ingredient in popular cold fighters, phenylephrine, may not offer genuine relief.

Bimekizumab is a novel, humanized monoclonal IgG1 antibody that potently and selectively neutralizes both IL-7A and IL-17F, which are key cytokines driving inflammatory processes in plaque psoriasis.

Artificial intelligence and machine learning can significantly benefit managed care pharmacy, specifically in contract reading and interpretation.